Because I'm not a trader. My view isn't next week or next month, I'm looking at 2029+
I believe that FDA approval is a matter of course and will simply be a green light to market. I'm here for post FDA approval, and the risk to me is how the market reacts to Sofrada. I am happy to take that particular risk as the Japanese market is already showing signs of sucess. Sofrada as a product sits in a sweet spot in terms of treatment where efficacy is (seemingly) good and is a non invasive treatment.
So for me, yes, I priced FDA approval into the current SP. In my mind, I purchased BOT because the likelyhood of FDA approval is extremely high. As I said in a previous post, I'm working on a 0.55 SP next year and I'm happy with that.
- Forums
- ASX - By Stock
- BOT
- Ann: Final Sofdra Labelling Discussions with FDA
Ann: Final Sofdra Labelling Discussions with FDA, page-85
-
-
- There are more pages in this discussion • 198 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $574.9M |
Open | High | Low | Value | Volume |
37.0¢ | 38.5¢ | 35.5¢ | $6.090M | 16.50M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 101678 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 79000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 101678 | 0.365 |
6 | 292344 | 0.360 |
12 | 860235 | 0.355 |
21 | 1087295 | 0.350 |
9 | 308466 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 79000 | 2 |
0.380 | 455594 | 6 |
0.385 | 138032 | 5 |
0.390 | 982736 | 12 |
0.395 | 1425000 | 6 |
Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |